Hou et al. (2018) recently reported that AQP9 expression was significantly up‐regulated in type 1 and type 2 diabetes mellitus and suggested that insulin down‐regulated AQP9 by inhibiting phosphorylated JNK and activating phosphorylated p38. Here, MAPK8 is linked to type 2 diabetes mellitus.